Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Eli Lilly and Company |
---|---|
Information provided by: | Eli Lilly and Company |
ClinicalTrials.gov Identifier: | NCT00071695 |
How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression
Condition | Intervention | Phase |
---|---|---|
Depression |
Drug: Duloxetine Hydrochloride Drug: Venlafaxine Extended Release |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder |
Estimated Enrollment: | 320 |
Study Start Date: | July 2003 |
Study Completion Date: | May 2004 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Easter Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | |
La Rochelle, France |
Study Director: | Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) | Eli Lilly and Company |
Study ID Numbers: | 6090, F1J-MC-HMBU |
Study First Received: | October 29, 2003 |
Last Updated: | May 17, 2007 |
ClinicalTrials.gov Identifier: | NCT00071695 |
Health Authority: | United States: Food and Drug Administration |
Dopamine Depression Mental Disorders Venlafaxine Mood Disorders |
Depressive Disorder, Major Depressive Disorder Serotonin Duloxetine Behavioral Symptoms |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Serotonin Uptake Inhibitors Pharmacologic Actions Serotonin Agents Therapeutic Uses Dopamine Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |